Kamei, Koichi
Ogura, Masao
Sato, Mai
Ito, Shuichi
Ishikura, Kenji
Article History
Received: 16 October 2017
Revised: 21 January 2018
Accepted: 23 January 2018
First Online: 9 February 2018
Compliance with ethical standards
:
: KK has received lecture fees from the Chugai Pharmaceutical Co., Ltd. SI has received lecture fees and/or grants from the Chugai Pharmaceutical Co., Ltd.; Zenyaku Kogyo Co., Ltd.; Asahi Kasei Pharma; Novartis Pharma K.K.; and Astellas Pharma Inc. KI has received lecture fees from the Asahi Kasei Pharma; Chugai Pharmaceutical Co., Ltd.; Zenyaku Kogyo Co., Ltd.; and Novartis Pharma K.K. and a consultant fee from Ono Pharmaceutical Co., Ltd.
: The design and execution of this study were in accordance with the ethical standards of the Declaration of Helsinki. The protocol was approved by the Ethics Committee of the National Center for Child Health and Development (no. 1505).
: For this type of study, formal informed consent is not required.